Instituto de Neurociencias (CSIC-UMH), Alicante, Spain.
Methods Mol Biol. 2021;2179:19-28. doi: 10.1007/978-1-0716-0779-4_4.
When referring to the epithelial-to-mesenchymal transition (EMT), readers are familiar with sentences alluding to its pivotal role both in embryonic development and in disease. Following that argument, usually there is a point on the importance of studying the process and the impact it has on the design of therapeutic strategies. However, it is also very common to find arguments on how the EMT is very difficult to tackle, being a somehow obscure and complex process, where the field cannot reach universal conclusions, particularly in pathological contexts. Even worse, it is sometimes defined as a process that cannot be described with universal markers, making it therefore very difficult for cancer studies, where there is a need to use optimal animal models and stratify patients for differential therapeutic strategies. In the face of all this, the question is whether you have been frightened off working on pathological EMTs, or even if you are not interested anymore and would prefer waiting till the field reaches a steady state of robust knowledge. Do not be afraid and be interested now. It only involves being more plastic, like the EMT itself.
当提到上皮-间充质转化(EMT)时,读者会熟悉一些句子,这些句子暗示了它在胚胎发育和疾病中的关键作用。基于这一论点,通常会有一个观点强调研究这一过程及其对治疗策略设计的影响的重要性。然而,也很常见的是,有人认为 EMT 非常难以解决,因为它是一个有些模糊和复杂的过程,该领域无法达成普遍结论,特别是在病理环境中。更糟糕的是,它有时被定义为一个不能用通用标志物来描述的过程,这使得癌症研究变得非常困难,因为需要使用最佳的动物模型并对患者进行分层,以采取不同的治疗策略。面对这一切,问题是你是否因为担心研究病理性 EMT 而望而却步,或者你是否已经不再感兴趣,宁愿等到该领域达到稳定的、可靠的知识状态。不要害怕,现在就参与进来。这只需要你更具可塑性,就像 EMT 本身一样。